Marked clozapine-induced slowing of EEG background over frontal, central, and parietal scalp areas in schizophrenic patients

Journal of Clinical Neurophysiology

Volumn 18, Issue 1, 2001, Pages 9-13

  Joutsiniemi, Sirkka Liisa ^a   Gross, Andres ^b   Appelberg, Björn ^b  

^a Tammiharju Mental Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Clozapine; Quantitative EEG; Schizophrenia; Traditional neuroleptics

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL LOBE; HUMAN; MALE; PARIETAL LOBE; SCHIZOPHRENIA; TOPOGRAPHY;

EID: 0035088398     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004691-200101000-00003     Document Type: Article

References (12)

1. EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients
2. Altered topography of EEG spectral content in schizophrenia
3. EEG abnormalities caused by clozapine treatment
4. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: Report of the American Academy of Neurology and the American Clinical Neurophysiology Society
5. QEEG profiles of psychiatric disorders
6. The incidence of clozapine-induced EEG abnormalities
7. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia
8. Abnormal EEG activities induced by psychotropic drugs
9. EEG abnormalities associated with clozapine treatment
10. The role of 5-HT3-like receptors in the action of clozapine
11. Brain region effects of clozapine on amino acid and monoamine transmission